Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

1 Growth Stock Down 76% to Buy and Hold

TheMotleyFool

0 0

1 Growth Stock Down 76% to Buy and Hold: https://g.foolcdn.com/editorial/images/692658/person-on-a-virtual-consultation-with-a-physician.jpg

Telemedicine specialist Teladoc (NYSE: TDOC) can't catch a break. After a horrible, no-good first-quarter earnings report that sent its shares tumbling, the healthcare company is suffering the same fate following the release of its second-quarter results.

Of course, Teladoc's issues in the stock market started before 2022, and the company's shares have been southbound for the past 12 months. Despite Teladoc's problems, there are good reasons to stick with the telehealth leader. Let's consider why.